Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2272921rdf:typepubmed:Citationlld:pubmed
pubmed-article:2272921lifeskim:mentionsumls-concept:C0184511lld:lifeskim
pubmed-article:2272921lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2272921lifeskim:mentionsumls-concept:C0071126lld:lifeskim
pubmed-article:2272921lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:2272921pubmed:issue11lld:pubmed
pubmed-article:2272921pubmed:dateCreated1991-2-27lld:pubmed
pubmed-article:2272921pubmed:abstractTextThe preparation and antitumor effects of 3'-deamino-3'-morpholino derivatives of pirarubicin are described. Di-N-alkylation of pirarubicin with bis(2-iodoethyl)ether gave 3'-morpholino-pirarubicin, which was converted into its 13-tosylhydrazone, 13-deoxy derivative and 13-(S)- and 13-(R)-dihydro derivatives. Intraperitoneal administration to murine tumors indicated that the effective dose ranges of the compounds having sp3 carbon at C-13 position were broader than those of the compounds having sp2 carbon. By oral administration, 13-(S)-dihydro isomer was more effective than 13-(R)-dihydro isomer.lld:pubmed
pubmed-article:2272921pubmed:languageenglld:pubmed
pubmed-article:2272921pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2272921pubmed:citationSubsetIMlld:pubmed
pubmed-article:2272921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2272921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2272921pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2272921pubmed:statusMEDLINElld:pubmed
pubmed-article:2272921pubmed:monthNovlld:pubmed
pubmed-article:2272921pubmed:issn0021-8820lld:pubmed
pubmed-article:2272921pubmed:authorpubmed-author:TakeuchiTTlld:pubmed
pubmed-article:2272921pubmed:authorpubmed-author:KondoSSlld:pubmed
pubmed-article:2272921pubmed:authorpubmed-author:IkedaDDlld:pubmed
pubmed-article:2272921pubmed:authorpubmed-author:KomuroKKlld:pubmed
pubmed-article:2272921pubmed:authorpubmed-author:NosakiKKlld:pubmed
pubmed-article:2272921pubmed:authorpubmed-author:AjitoKKlld:pubmed
pubmed-article:2272921pubmed:issnTypePrintlld:pubmed
pubmed-article:2272921pubmed:volume43lld:pubmed
pubmed-article:2272921pubmed:ownerNLMlld:pubmed
pubmed-article:2272921pubmed:authorsCompleteYlld:pubmed
pubmed-article:2272921pubmed:pagination1464-70lld:pubmed
pubmed-article:2272921pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:meshHeadingpubmed-meshheading:2272921-...lld:pubmed
pubmed-article:2272921pubmed:year1990lld:pubmed
pubmed-article:2272921pubmed:articleTitleImproved antitumor effects of 3'-deamino-3'-morpholino derivatives of pirarubicin.lld:pubmed
pubmed-article:2272921pubmed:affiliationInstitute of Microbial Chemistry, Tokyo, Japan.lld:pubmed
pubmed-article:2272921pubmed:publicationTypeJournal Articlelld:pubmed